Structure Therapeutics (GPCR) Other Accumulated Expenses (2022 - 2026)

Quarterly Other Accumulated Expenses rose 221.24% to $8.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.3 million through Mar 2026, up 221.24% year-over-year, with the annual reading at $12.4 million for FY2025, 127.18% up from the prior year.

Structure Therapeutics' Other Accumulated Expenses history spans 5 years, with the latest figure at $8.3 million for Q1 2026.

  • Other Accumulated Expenses came in at $8.3 million for Q1 2026, down from $12.4 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $12.4 million in Q4 2025 to a low of $454000.0 in Q4 2022.
  • The 5-year median for Other Accumulated Expenses is $2.9 million (2024), against an average of $3.7 million.
  • Year-over-year, Other Accumulated Expenses soared 399.24% in 2024 and then tumbled 60.96% in 2025.
  • Structure Therapeutics' Other Accumulated Expenses stood at $454000.0 in 2022, then skyrocketed by 223.57% to $1.5 million in 2023, then soared by 271.68% to $5.5 million in 2024, then soared by 127.18% to $12.4 million in 2025, then plummeted by 32.69% to $8.3 million in 2026.
  • Per Business Quant, the three most recent readings for GPCR's Other Accumulated Expenses are $8.3 million (Q1 2026), $12.4 million (Q4 2025), and $5.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Structure Therapeutics 8.43 Bn 8.43 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 8.35 Mn
Dec 31, 2025 12.40 Mn
Sep 30, 2025 5.19 Mn
Jun 30, 2025 1.23 Mn
Mar 31, 2025 2.60 Mn
Dec 31, 2024 5.46 Mn
Sep 30, 2024 4.92 Mn
Jun 30, 2024 3.14 Mn
Mar 31, 2024 3.29 Mn
Dec 31, 2023 1.47 Mn
Sep 30, 2023 1.44 Mn
Jun 30, 2023 1.37 Mn
Mar 31, 2023 658,000.00
Dec 31, 2022 454,000.00